cegedim 2012 pharma insights pr 03dec12

Upload: zaccady

Post on 04-Apr-2018

216 views

Category:

Documents


0 download

TRANSCRIPT

  • 7/30/2019 Cegedim 2012 Pharma Insights PR 03Dec12

    1/2

    Page 1

    PRESS RELEASE

    Cegedim Relationship Managements 3rd Annual US Pharma

    Insights Survey Reveals 74% of Pharma Execs Are Most

    Concerned About the Changing Commercial Business Model

    Survey Results Illustrate Strategic Evolutions in Business Models, Next

    Generation Tech Trends and Social Media

    Bedminster, NJ December 3, 2012Cegedim Relationship Managementtoday announced the

    release of its thought leadership report,2012 US Pharma Insights, which provides the results of its

    third annual survey of life sciences decision makers on current challenges, upcoming business

    developments, preferred strategies and next generation technology. Leveraging analysis from three

    years of responses, the report delivers a holistic view of present and future trends.

    The Shape of Change in Decision Making, Industry Concerns and the Future

    Sustained industry concerns, evolved decision making leadership and new future strategies top

    2012s trends. Aligning with previous years responses, 74% of respondents ranked the changing

    commercial business model as their first, second or third priority of concern; followed by regulatory

    reform (62%) and market access (53%). Additionally, decision making leadership now sources from

    executive management for most technology decisions (46%); and strategy/business development

    for main business model/process changes (55%). Further, respondents clearly defined the following

    prioritized changes for the near future: increased focus on market access strategies (64%), primary

    sales force realignment (38%) and increased focus on managed markets (35%).

    Boosts in Field Centric Tablet Usage, Preference for Apple Mobile OS and

    Noteworthy Social Media GainsSurveyed executives cite continued focus on field centric tablet usage, their preferred mobile OS

    and social media. Eight out of ten (80%) currently use or will be using tablets, and unsurprisingly,

    field sales/account management (61%) account for the most active tablet users. Further, exactly

    half selected Apple OS as their favorite mobile platform. In terms of social media trending, the

    report underscores significant increases in usage between 2011 and 2012. LinkedIn (96%) and

    Facebook (70%) represent respondents leading channels with marketing (64%), PR (42%) and

    sales (38%) make up the most active departments. Lastly, despite minor social media budgets,

    those surveyed exhibited notable gains according to the report.

    The 2012 US report details exactly how and where our current industry climate is impacting

    strategy and operations. Respondents report strong focus on business model changes, as well as

    next generation and mobile technologies, saidAngela Miccoli, President of North America,

    Cegedim Relationship Management. In order to further our standing as the leader in pharma CRM,

    data and compliance solutions, we strive to consistently monitor the pulse of the industry, and

    empower our customers with our proven insights and expertise.

    Cegedim Relationship Management, the global leader in Customer Relationship Management,

    Healthcare Data, Regulatory Compliance and Marketing Solutions for the Life Sciences industry,

    conducted the thought leadership survey in during the second half of 2012.Please click here to

    access the complete report.

    Apple is a registered trademark of Apple Inc. Other company and product names may be trademarks of their respective owners.

    http://crm.cegedim.com/Pages/default.aspxhttp://crm.cegedim.com/Pages/default.aspxhttp://crm.cegedim.com/Pages/default.aspxhttp://crm.cegedim.com/featured/pharma-insights-2012/Documents/index.htmlhttp://crm.cegedim.com/featured/pharma-insights-2012/Documents/index.htmlhttp://crm.cegedim.com/featured/pharma-insights-2012/Documents/index.htmlhttp://crm.cegedim.com/featured/pharma-insights-2012/Documents/index.htmlhttp://crm.cegedim.com/featured/pharma-insights-2012/Documents/index.htmlhttp://crm.cegedim.com/featured/pharma-insights-2012/Documents/index.htmlhttp://crm.cegedim.com/featured/pharma-insights-2012/Documents/index.htmlhttp://crm.cegedim.com/featured/pharma-insights-2012/Documents/index.htmlhttp://crm.cegedim.com/featured/pharma-insights-2012/Documents/index.htmlhttp://crm.cegedim.com/featured/pharma-insights-2012/Documents/index.htmlhttp://crm.cegedim.com/Pages/default.aspx
  • 7/30/2019 Cegedim 2012 Pharma Insights PR 03Dec12

    2/2

    Page 2

    PRESS RELEASE

    AboutCegedimRelationshipManagement:

    Cegedim Relationship Management is the Life Sciences industrys leading provider of CustomerRelationship Management (CRM) solutions. Designed specifically for Life Sciences, the companysinnovative business solutions incorporate a thorough understanding of local, regional and worldwidetrends. Cegedim Relationship Management enables more than 200,000 users in many of the worldsmost innovative companies to stay ahead of market challenges. In addition to CRM, CegedimRelationship Management also provides marketing, data optimization and regulatory compliancesolutions in more than 80 countries. Cegedim Relationship Management is part of the France-basedCegedim S.A. Group.

    To learn more, please visit:www.cegedim.com/rm .

    Follow Cegedim Relationship Management onLinkedIn andTwitter.

    AboutCegedim:

    Founded in 1969, Cegedim is a global technology and services company specializing in the healthcarefield. Cegedim supplies services, technological tools, specialized software, data flow managementservices and databases. Its offerings are targeted notably at healthcare industries, life sciencescompanies, healthcare professionals and insurance companies. The world leader in life sciences CRM,Cegedim is also one of the leading suppliers of strategic healthcare industry data. Cegedim employs8,200 people in more than 80 countries and generated revenue of 911 million in 2011. Cegedim SA islisted in Paris (EURONEXT: CGM).To learn more, please visit: www.cegedim.com.

    Contacts: Drew BUSTOSCegedim Relationship ManagementGlobal CommunicationsTel: +1 (908) 443.2451

    [email protected]

    Aude BALLEYDIERCegedimMedia RelationsTel: +33 (0)1 49 09 68 81

    [email protected]

    http://www.cegedimrm.com/rmhttp://www.cegedimrm.com/rmhttp://www.cegedimrm.com/rmhttp://www.linkedin.com/company/cegedim-relationship-managementhttp://www.linkedin.com/company/cegedim-relationship-managementhttps://twitter.com/#%21/CegedimRMhttps://twitter.com/#%21/CegedimRMhttps://twitter.com/#%21/CegedimRMmailto:[email protected]:[email protected]:[email protected]:[email protected]:[email protected]:[email protected]://twitter.com/#%21/CegedimRMhttp://www.linkedin.com/company/cegedim-relationship-managementhttp://www.cegedimrm.com/rm